Proteolysis of cyclic AMP phosphodiesterase-II attenuates its ability to be inhibited by compounds which exert positive inotropic actions in cardiac tissue
- 30 November 1987
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 36 (23), 4047-4054
- https://doi.org/10.1016/0006-2952(87)90560-0
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Identification and characterization of both the cytosolic and particulate forms of cyclic GMP-stimulated cyclic AMP phosphodiesterase from rat liverBiochemical Journal, 1986
- A New Generation of Phosphodiesterase Inhibitors: Multiple Molecular Forms of Phosphodiesterase and the Potential for Drug SelectivityJournal of Medicinal Chemistry, 1985
- Selective inhibitors of three forms of cyclic nucleotide phosphodiesterasesTrends in Pharmacological Sciences, 1984
- Positive Inotropic AgentsAnnual Review of Pharmacology and Toxicology, 1984
- Proteolytic activation and solubilization of endoplasmic-reticulum cyclic AMP phosphodiesterase activityBiochemical Journal, 1983
- Agents for the treatment of heart failureMedicinal Research Reviews, 1983
- Identification and properties of cyclic nucleotide phosphodiesterasesMolecular and Cellular Endocrinology, 1982
- Biochemical Studies on the Mechanism of Cardiotonic Activity of MDL 17,043Journal of Cardiovascular Pharmacology, 1982
- A peripheral and an intrinsic enzyme constitute the cyclic AMP phosphodiesterase activity of rat liver plasma membranesBiochemical Journal, 1980
- A Micro Biuret Method for Protein Determination Determination of Total Protein in Cerebrospinal FluidScandinavian Journal of Clinical and Laboratory Investigation, 1953